Geisinger Health System
Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk
The health system will partner with the NCI to look for new cancer risk variants in a large population biobank, in the hopes of improving screening and care.
Exome Sequencing Provides Molecular Diagnosis in Portion of Cerebral Palsy Cases
A Geisinger and GeneDx team found exome sequencing can lead to a molecular diagnosis for 10 percent to 33 percent of people with cerebral palsy.
Geisinger National Experts Join Genome Medical to Help Implement Population Genomics Programs
Premium
The Geisinger National Precision Health Initiative ended in 2019 but its leaders joined Genome Medical to bring genomics-informed care to other health systems.
Chatbots Could Help Human Genetic Counselors Focus on Patient Concerns
Panelists at the NSGC annual meeting said artificial intelligence approaches like chatbots could complement traditional genetic counseling approaches.
Dilated Cardiomyopathy Risk Increased in Only Some With Titin Truncations
Geisinger and UPenn researchers found that Titin truncations revealed by exome sequencing increased DCM risk in those with European but not with African ancestry.